Pharmaceutical Policy Experts™

divider

Rx|X’s consultative approach – including thorough analysis & clear recommendations – provides 340B drug discount program stakeholders with implementable plans to help ensure program compliance. 

Unlike other consultancies that offer software or multiple health care-related services, Rx|X’s auditing is 340B-focused, truly independent, respected and reliable.  Our almost 20 years of direct experience with the 340B program places Rx|X in a unique position to offer perspective, a proper assessment of potential issues, and sound, unbiased advice.

We offer high-quality research, analytics, and consulting services, based on our senior-level experience with the Office of Inspector General, as well as our ongoing engagements with federal and state governments, 340B covered entities, law firms and advocacy organizations.  This broad and varied experience gives us a distinct advantage in understanding all relevant issues and offering tailored, pragmatic solutions for our clients.

So, how can the Rx|X experts help you?

 


Let Rx|X help you “X” the box